ADVANZ PHARMA UK AND IRELAND LIMITED

Company number 09793586

Date	Type	Description	View / Download
04 Jul 2022	TM01	Termination of appointment of Willem Wouter Van Weperen as a director on 1 July 2022	(1 page)
04 Jul 2022	TM01	Termination of appointment of Michael Gemellaro as a director on 1 July 2022	(1 page)
04 Jul 2022	TM02	Termination of appointment of Quayseco Limited as a secretary on 1 July 2022	(1 page)
11 Nov 2021	AA	Full accounts made up to 31 December 2020	(28 pages)
01 Nov 2021	TM01	Termination of appointment of Caroline Stockwell as a director on 29 October 2021	(1 page)
11 Oct 2021	CH01	Director's details changed for Willem Wouter Van Weperen on 10 October 2021	(2 pages)
07 Oct 2021	AP01	Appointment of Willem Wouter Van Weperen as a director on 4 October 2021	(2 pages)
01 Oct 2021	CS01	Confirmation statement made on 30 September 2021 with no updates	(3 pages)
25 May 2021	AP01	Appointment of Mr Michael Gemellaro as a director on 20 May 2021	(2 pages)
25 May 2021	AP01	Appointment of Rocco Venezia as a director on 20 May 2021	(2 pages)
26 Mar 2021	TM01	Termination of appointment of Sandip Kapadia as a director on 26 March 2021	(1 page)
23 Mar 2021	AP01	Appointment of Caroline Stockwell as a director on 17 March 2021	(2 pages)
05 Jan 2021	AA	Full accounts made up to 31 December 2019	(27 pages)
05 Oct 2020	CS01	Confirmation statement made on 30 September 2020 with updates	(4 pages)
07 Oct 2019	AA	Full accounts made up to 31 December 2018	(28 pages)
01 Oct 2019	CS01	Confirmation statement made on 30 September 2019 with updates	(5 pages)
27 Feb 2019	SH01	Statement of capital following an allotment of shares on 25 February 2019 GBP 10	(3 pages)
13 Dec 2018	AA	Full accounts made up to 31 December 2017	(26 pages)
02 Oct 2018	CS01	Confirmation statement made on 30 September 2018 with updates	(5 pages)
10 May 2018	TM01	Termination of appointment of Daniel Carey Cazel Hood as a director on 9 May 2018	(1 page)
17 Jan 2018	AP01	Appointment of Mr Giancarlo Notarianni as a director on 31 December 2017	(2 pages)
16 Jan 2018	TM01	Termination of appointment of Stewart Charles Sharpe as a director on 31 December 2017	(1 page)
20 Dec 2017	SH01	Statement of capital following an allotment of shares on 18 December 2017 GBP 8	(3 pages)
05 Oct 2017	CS01	Confirmation statement made on 30 September 2017 with updates	(5 pages)
05 Oct 2017	CH01	Director's details changed for Mr Daniel Carey Cazel Hood on 29 September 2017	(2 pages)